OPTIC NEUROPATHY IN PATIENTS WITH GLIOBLASTOMA RECEIVING BEVACIZUMAB

被引：37
|
作者：
Sherman, J. H. [2 ]
Aregawi, D. G.
Lai, A. [5 ]
Fathallah-Shaykh, H. M. [6 ]
Bierman, P. J. [7 ]
Linsky, K. [8 ]
Larner, J. M. [3 ]
Newman, S. A. [4 ]
Schiff, D. [1 ,2 ]
机构：
[1] Univ Virginia, Ctr Hlth Sci, Dept Neurol Surg, Charlottesville, VA 22908 USA
[2] Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA
[3] Univ Virginia, Dept Radiat Oncol, Charlottesville, VA 22908 USA
[4] Univ Virginia, Dept Ophthalmol, Charlottesville, VA 22908 USA
[5] Univ Calif Los Angeles, Med Ctr, Neurooncol Program, Los Angeles, CA 90024 USA
[6] Rush Univ, Div Neurosci, Sect Neurooncol, Chicago, IL 60612 USA
[7] Univ Nebraska, Dept Internal Med, Sect Oncol & Hematol, Omaha, NE 68182 USA
[8] Columbia Univ, Dept Med, New York, NY USA
来源：
NEUROLOGY | 2009年 / 73卷 / 22期
关键词：
CANCER;
D O I：
10.1212/WNL.0b013e3181c3fd00
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1924 / 1926
页数：6
相关论文
共 50 条
  • [1] OPTIC NEUROPATHY IN PATIENTS WITH GLIOBLASTOMA RECEIVING BEVACIZUMAB
    Chamberlain, Marc C.
    Raizer, Jeffrey
    [J]. NEUROLOGY, 2010, 75 (03) : 289 - 290
  • [2] OPTIC NEUROPATHY IN PATIENTS WITH GLIOBLASTOMA RECEIVING BEVACIZUMAB Reply
    Schiff, David
    Sherman, Jonathan H.
    [J]. NEUROLOGY, 2010, 75 (03) : 290 - 290
  • [3] CASE REPORT: OPTIC NEUROPATHY IN A PATIENT WITH GLIOBLASTOMA RECEIVING BEVACIZUMAB
    Fishman, Robert A.
    Happ, Erik
    Stevens, Tracey
    Kunschner, Lara
    [J]. NEURO-ONCOLOGY, 2010, 12 : 1 - 1
  • [4] Case Report: Optic Neuropathy in a Patient with Glioblastoma Receiving Bevacizumab
    Fishman, Robert A.
    Kunschner, Lara
    Happ, Erik
    [J]. ANNALS OF NEUROLOGY, 2011, 70 : S76 - S76
  • [5] A Prospective Single Institution Study of Optic Neuropathy in 10 Patients with Glioblastoma Receiving Bevacizumab
    Fishman, Robert
    Kunschner, Lara
    [J]. NEUROLOGY, 2012, 78
  • [6] OPTIC NEUROPATHY IN PATIENTS WITH MALIGNANT GLIOMAS TREATED WITH BEVACIZUMAB
    Sherman, Jonathan
    Aregawi, Dawit
    Lai, Albert
    Rosenfeld, Steven
    Fathallah-Shaykh, Hassan
    Larner, James
    Newman, Steven
    Schiff, David
    [J]. NEURO-ONCOLOGY, 2008, 10 (05) : 816 - 816
  • [7] OPTIC NEUROPATHY IN PATIENTS WITH MALIGNANT GLIOMAS TREATED WITH BEVACIZUMAB
    Sherman, J. H.
    Aregawi, D. G.
    Lai, A.
    Rosenfeld, S. S.
    Fathallah-Shaykh, H. M.
    Larner, J. M.
    Newman, S. A.
    Schiff, D.
    [J]. NEURO-ONCOLOGY, 2008, 10 (06) : 1076 - 1076
  • [8] OPTIC NEUROPATHY IN GLIOMA PATIENTS AFTER RECEIVING RADIOTHERAPY AND BEVACIZUMAB: RISK FACTORS AND RELATED QUALITY OF LIFE ISSUES
    Fu, Beverly Dan
    Bota, Daniela A.
    [J]. NEURO-ONCOLOGY, 2011, 13 : 50 - 50
  • [9] RETROSPECTIVE REVIEW OF THE TREATMENT OF VENOUS THROMBOEMBOLISM IN GLIOBLASTOMA PATIENTS RECEIVING BEVACIZUMAB
    Lomax, Jerica
    Kong, Xiao-Tang
    [J]. NEURO-ONCOLOGY, 2023, 25
  • [10] Diffusion restriction as a predictor of response in recurrent glioblastoma patients receiving bevacizumab
    Wu, J.
    Gilbert, M. R.
    De Groot, J. F.
    Yung, W. A.
    Puduvalli, V. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345